Cause Of Prostate Cancer
Published on Mar 22 2010, in the categories: Useful Info
Cancer, nowadays seams like everyone is suffering from something or something else. More and more people discover they suffer from suffer from different types of cancer such as bone cancer, skin cancer, lung cancer and the most frequent between men prostate cancer.
Prostate cancer remains even today one of the causes of cancer death worldwide. One most firstly achieve a fundamental understanding of the nature of the changes which occur in a man's body, the changes which initiate and progress this malignancy. This knowledge is critical in helping to define new approaches for therapy.Every little changes within the epithelium, its closest surrounding stromal environment, and also sites of metastasis must be discovered and understood in relationship to the progression of cancer and therapeutic response or failure.
In what concerns the research done in the domain of prostate cancer it has been acknowledged that the insulin-like growth factor signaling axis is thought to play a key role in the progression of prostate carcinoma. Medics have described this as consisting of two ligands, two receptors and also six related high-affinity binding proteins .This altered expression of those elements axis members has been thought to be implicated in the development of many other different types of cancers, including prostate, the one we are talking about.
Throughout the years scientists have established a few prostate cancer cell line in order to investigate the mechanism involved in the progression of prostate cancer.They are called, PC-3 and DU-145 and they are commonly used prostate cancer cell lines. What medics call the LNCaP cancer cell line has been established from a human lymph node metastatic lesion of prostatic adenocarcinoma.Other cell lines such as PC-3 and DU-145 cells have been established from human prostatic adenocarcinoma metastatic to bone and to brain Furthermore scientists say that LNCaP cells express androgen receptor;but however, PC-3 and DU-145 cells are said to express very little or no AR. AR, an androgen-activated. Another break through is that of the developing of the prostate as it being dependent on androgen signaling mediated through AR, and AR,as you can see in another article "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693411/" here, thus this being also important during the development of prostate cancer.
New evidence for the prostate cancer treatment has raised over the last few years, and the longstanding controversies in this treatment have reappeared. One of the most used treatments that of neoadjuvant hormonal therapy prior to radical prostatectomy is clear to decreases positive surgical margin rate , however longer follow-up is needed in order to support survival improvement of this combined modality therapy. Another type is that of androgen deprivation combined with radiation therapy that has appeared to improve disease-free survival .Moreover another approach to the locally advanced prostate cancer is the use of a three-dimensional conformal radiation therapy that may improve long term outcome. We most always have in mind that the data are currently insufficient to conclude and have a clear idea on what the development of different types of treatment can or can not help in improving if not curing prostate cancer. Last but not least in advanced prostate cancer recent data have suggested that immediate hormonal therapy improves survival.
Thus the world of research in the area of cancer, and prostate cancer is still open, and might in the end have much more greater results than we or anybody else can expect. We will just have to wait and see what the never ending changes that happen in all the domains bring to the table.
Prostate cancer remains even today one of the causes of cancer death worldwide. One most firstly achieve a fundamental understanding of the nature of the changes which occur in a man's body, the changes which initiate and progress this malignancy. This knowledge is critical in helping to define new approaches for therapy.Every little changes within the epithelium, its closest surrounding stromal environment, and also sites of metastasis must be discovered and understood in relationship to the progression of cancer and therapeutic response or failure.
In what concerns the research done in the domain of prostate cancer it has been acknowledged that the insulin-like growth factor signaling axis is thought to play a key role in the progression of prostate carcinoma. Medics have described this as consisting of two ligands, two receptors and also six related high-affinity binding proteins .This altered expression of those elements axis members has been thought to be implicated in the development of many other different types of cancers, including prostate, the one we are talking about.
Throughout the years scientists have established a few prostate cancer cell line in order to investigate the mechanism involved in the progression of prostate cancer.They are called, PC-3 and DU-145 and they are commonly used prostate cancer cell lines. What medics call the LNCaP cancer cell line has been established from a human lymph node metastatic lesion of prostatic adenocarcinoma.Other cell lines such as PC-3 and DU-145 cells have been established from human prostatic adenocarcinoma metastatic to bone and to brain Furthermore scientists say that LNCaP cells express androgen receptor;but however, PC-3 and DU-145 cells are said to express very little or no AR. AR, an androgen-activated. Another break through is that of the developing of the prostate as it being dependent on androgen signaling mediated through AR, and AR,as you can see in another article "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693411/" here, thus this being also important during the development of prostate cancer.
New evidence for the prostate cancer treatment has raised over the last few years, and the longstanding controversies in this treatment have reappeared. One of the most used treatments that of neoadjuvant hormonal therapy prior to radical prostatectomy is clear to decreases positive surgical margin rate , however longer follow-up is needed in order to support survival improvement of this combined modality therapy. Another type is that of androgen deprivation combined with radiation therapy that has appeared to improve disease-free survival .Moreover another approach to the locally advanced prostate cancer is the use of a three-dimensional conformal radiation therapy that may improve long term outcome. We most always have in mind that the data are currently insufficient to conclude and have a clear idea on what the development of different types of treatment can or can not help in improving if not curing prostate cancer. Last but not least in advanced prostate cancer recent data have suggested that immediate hormonal therapy improves survival.
Thus the world of research in the area of cancer, and prostate cancer is still open, and might in the end have much more greater results than we or anybody else can expect. We will just have to wait and see what the never ending changes that happen in all the domains bring to the table.
If you liked this post, subscribe to our blog by filling your e-mail address below:
Want to add something? Post your comments